For years those suffering from rheumatoid arthritis have had to resort to twice monthly shots to seek relief from the debilitating pain the disease causes. Thanks to a medical breakthrough a new pill may be greenlighted by the FDA this month that will change the face of rheumatoid arthritis treatment. The pill, called tofacitinib, already passed approval by a USDA advisory panel back in May and is now in the final stages of final approval before heading ot market. The pill is not a cure for rheumatoid arthritis, an autoimmune disease in which the body attacks its own tissue, but could cause significant pain relief. Unfortunately much like its precursor it is not without risk of serious side effects including infections, blood and lymphatic problems and cancer. Two studies have been published in the New England Journal of Medicine espousing the benefits of the new drug.